首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Method development and validation of Sofosbuvir and iedipasvirin by HPLC: A Review
【24h】

Method development and validation of Sofosbuvir and iedipasvirin by HPLC: A Review

机译:HPLC法开发Sofosbuvir和iedipasvirin的方法开发和验证:综述

获取原文
           

摘要

The aim of this review article is emphasizing on development and validation protocol which will used to develop and validate accurate, simple, selective and specific spectrophotometric methods for the determination of Sofosbuvir (SOF) and Ledipasvir (LDV) in pure and in their dosage forms. Thus it is necessary to develop methods for analysis with the help of number of analytical techniques which are available for the estimation of the drugs in combination. The analyst were determine the Specific, accurate, simple, selective and stability-indicating RP-HPLC method is developed and validated for simultaneous determination of sofosbuvir and ledipasvir in tablet dosage form.
机译:本文的目的是强调开发和验证协议,该协议将用于开发和验证准确,简单,选择性和特异的分光光度法,用于测定纯的和剂型的Sofosbuvir(SOF)和Ledipasvir(LDV)。因此,有必要借助许多分析技术来开发分析方法,这些方法可用于组合药物的估计。分析人员确定了开发,验证了特异性,准确,简单,选择性和稳定性指示的RP-HPLC方法,用于同时测定片剂剂型中的Sofosbuvir和ledipasvir。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号